I'll tell you exactly what it says. It says Magna will give BioHeart up to 3 MILLION dollars to continue its pipeline progress. Forget dilution... A stocks PPS is based on what a buyer is willing to pay. So let me ask you a simple question. What do you believe BioHeart's PPS should be or how much would you pay per share of a company that is a phase 3 leader in the field of regenerative medicine (IMO could be the next boom once the field treatment is approved), has already penetrated markets worldwide and has continual revenue increase quarter over quarter as well as a top notch leadership team with a proven track record (I'll leave the DD up to you) good luck.
News 
Market Data 
Discover 
